| Mark Alan Popp, OD | |
|
447 Atlantic Blvd, Atlantic Beach, FL 32233-4004 | |
| (904) 247-0211 | |
| (904) 246-6115 |
| Full Name | Mark Alan Popp |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 40 Years |
| Location | 447 Atlantic Blvd, Atlantic Beach, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225089295 | NPI | - | NPPES |
| 078899600 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | OPC1956 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gateway Vision Inc | 8022029222 | 2 |
News Archive
While the physiological damage and social havoc created by alcohol abuse and dependency are well-known, it is also true that light-to-moderate drinking has certain health benefits.
A trial on shunts used to direct blood flow to the lungs, led by researchers at the University of Michigan's C.S. Mott Children's Hospital, will lead to better outcomes for kids worldwide born with hypoplastic left heart syndrome, the most common severe heart birth defect.
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced that it has actively started enrolling patients in the Luna Interbody System for Fusion Trial.
The Associated Press/BusinessWeek examines the Singapore-based company Rigel Technology's efforts to sell "state-of-the-art portable, fertilizer-making, toilets for as low as $30" in developing countries. "Experts estimate about 2.5 billion people lack functioning, hygienic toilets and instead excrete in the open, a habit that can contaminate water supplies and spread diseases such as E. coli bacteria and other viruses," the publication writes.
Targacept, Inc today announced top-line results from a Phase 2 proof of concept trial of TC-5619 as a treatment for adults with attention deficit/hyperactivity disorder.
› Verified 8 days ago
| Provider Name | Gateway Vision Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205885886 PECOS PAC ID: 8022029222 Enrollment ID: O20060602000127 |
News Archive
While the physiological damage and social havoc created by alcohol abuse and dependency are well-known, it is also true that light-to-moderate drinking has certain health benefits.
A trial on shunts used to direct blood flow to the lungs, led by researchers at the University of Michigan's C.S. Mott Children's Hospital, will lead to better outcomes for kids worldwide born with hypoplastic left heart syndrome, the most common severe heart birth defect.
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced that it has actively started enrolling patients in the Luna Interbody System for Fusion Trial.
The Associated Press/BusinessWeek examines the Singapore-based company Rigel Technology's efforts to sell "state-of-the-art portable, fertilizer-making, toilets for as low as $30" in developing countries. "Experts estimate about 2.5 billion people lack functioning, hygienic toilets and instead excrete in the open, a habit that can contaminate water supplies and spread diseases such as E. coli bacteria and other viruses," the publication writes.
Targacept, Inc today announced top-line results from a Phase 2 proof of concept trial of TC-5619 as a treatment for adults with attention deficit/hyperactivity disorder.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Alan Popp, OD 447 Atlantic Blvd, Atlantic Beach, FL 32233-4050 Ph: (904) 247-0211 | Mark Alan Popp, OD 447 Atlantic Blvd, Atlantic Beach, FL 32233-4004 Ph: (904) 247-0211 |
News Archive
While the physiological damage and social havoc created by alcohol abuse and dependency are well-known, it is also true that light-to-moderate drinking has certain health benefits.
A trial on shunts used to direct blood flow to the lungs, led by researchers at the University of Michigan's C.S. Mott Children's Hospital, will lead to better outcomes for kids worldwide born with hypoplastic left heart syndrome, the most common severe heart birth defect.
Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced that it has actively started enrolling patients in the Luna Interbody System for Fusion Trial.
The Associated Press/BusinessWeek examines the Singapore-based company Rigel Technology's efforts to sell "state-of-the-art portable, fertilizer-making, toilets for as low as $30" in developing countries. "Experts estimate about 2.5 billion people lack functioning, hygienic toilets and instead excrete in the open, a habit that can contaminate water supplies and spread diseases such as E. coli bacteria and other viruses," the publication writes.
Targacept, Inc today announced top-line results from a Phase 2 proof of concept trial of TC-5619 as a treatment for adults with attention deficit/hyperactivity disorder.
› Verified 8 days ago
Gateway Vision Inc Optometrist Medicare: Medicare Enrolled Practice Location: 447 Atlantic Blvd, Suite # 1, Atlantic Beach, FL 32233 Phone: 904-247-0211 Fax: 904-246-6115 |